| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |